Admission Date:  [**2140-9-15**]              Discharge Date:   [**2140-9-21**]  Date of Birth:  [**2104-9-10**]             Sex:   F  Service: MEDICINE  Allergies: Tape [**1-25**]"X10YD / Augmentin / Hydrocodone / Levofloxacin / Ciprofloxacin / fentanyl / Keflex / ceftriaxone / Ativan  Attending:[**Last Name (NamePattern1) 9662**] Chief Complaint: Diabetic ketoacidosis  Major Surgical or Invasive Procedure: None   History of Present Illness: 36F with DMI (last A1c 11 on [**2140-8-22**]) and gastroparesis presented with intractable nausea and vomiting on [**2140-9-15**] and was admitted to the medicine service.
She has previously responded well to ativan and erythromycin.
While in the ED her BP rose to 196/106, which responded well to labetalol 10mg, ativan 1mg IV x 2 doses, zofran 4mg x1, and metoclopramide 10mg x1.
She was given 2 units of humalog initially, followed by an additional 4units 4 hours later.
In the morning, she was noted to have elevated blood glucose on AM labs:  Na 147 K 4.7 Cl 106 HCO3 13 BUN 36 Cr 1.6 Glucose 545 (from 171) with anion gap  WBC 13 Hgb 10.5 (baseline 10.8-11.8) Plt 397  ABG 7.31/30/110/16 lactate 1.7  Past Medical History: -Type 1 DM c/b retinopathy ("quiescent" proliferative on last eye exam, [**4-/2136**]), nephropathy (nodular glomerulosclerosis on renal  bx [**2139-9-15**]; baseline Cr ~1.0-1.1 in [**12/2139**]), and gastroparesis.
-Barrett's esophagitis, GERD, gastritis, PUD (antral ulcer [**2132**])  -HLD -HTN -dCHF LVEF >60% in [**8-/2139**] -normocytic anemia -acquired hemophilia (FVIII inhibitor in [**2132**]) treated w/steroids and rituximab -anti-E and warm autoantibody (negative Coombs) -hydronephrosis -osteoporosis ([**2138-11-12**] T-score L spine -2.2, femoral neck -3.1)  -migraines -depression -h/o avascular necrosis -h/o severe hyperemesis gravidarum requiring TPN -h/o PEA arrest during renal biopsy [**2139-9-15**] (on fentanyl and versed)  Social History: Re-married, lives at home with mother, husband, and 8-year-old son from first marriage.
Physical Exam: ADMISSION PHYSICAL EXAM T 97.6 HR 122 BP 156/97 RR 17 O2 97%RA GENERAL - sleepy ill appearing F, but in NAD HEENT - NC/AT, PERRL, EOMI, sclerae anicteric, MMM, OP clear NECK - supple LUNGS - Lungs are clear to ausculatation bilaterally, moving air well and symmetrically, resp unlabored, no accessory muscle use  HEART - RRR, S1-S2 clear and of good quality without murmurs, rubs or gallops ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no rebound/guarding EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs)  NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength [**5-28**] throughout, sensation grossly intact throughout, DTRs 2+ and symmetric  DISCHARGE PHYSICAN EXAM T 98.1 HR 100 BP 140/50 RR 18 O2 98% RA GENERAL - awake and alert in NAD HEENT - NC/AT, PERRL, EOMI, sclerae anicteric, MMM, OP clear NECK - supple LUNGS - Lungs are clear to ausculatation bilaterally, moving air well and symmetrically, resp unlabored, no accessory muscle use  HEART - RRR, S1-S2 clear and of good quality without murmurs, rubs or gallops ABDOMEN - soft/NT/ND, no masses or HSM, no rebound/guarding EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs)  NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength [**5-28**] throughout, sensation grossly intact throughout, DTRs 2+ and symmetric   Pertinent Results: ADMISSION LABS [**2140-9-15**] 03:00PM BLOOD WBC-8.9 RBC-3.82* Hgb-11.8* Hct-35.5* MCV-93 MCH-30.9 MCHC-33.3 RDW-13.4 Plt Ct-427 [**2140-9-15**] 03:00PM BLOOD Neuts-82.2* Lymphs-15.1* Monos-1.3* Eos-0.7 Baso-0.7 [**2140-9-15**] 03:00PM BLOOD Glucose-222* UreaN-52* Creat-1.8* Na-141 K-4.3 Cl-99 HCO3-28 AnGap-18 [**2140-9-15**] 03:00PM BLOOD ALT-13 AST-16 AlkPhos-87 TotBili-0.2 [**2140-9-15**] 11:51PM BLOOD Calcium-8.6 Phos-2.9 Mg-2.1 [**2140-9-15**] 03:00PM BLOOD Albumin-3.7 [**2140-9-16**] 10:05AM BLOOD Type-ART pO2-110* pCO2-30* pH-7.31* calTCO2-16* Base XS--9 [**2140-9-16**] 11:57PM BLOOD Glucose-159* Na-143 K-3.6 Cl-115* calHCO3-23  DISCHARGE LABS [**2140-9-21**] 05:51AM BLOOD WBC-7.2 RBC-2.89* Hgb-9.0* Hct-27.1* MCV-94 MCH-31.1 MCHC-33.1 RDW-13.5 Plt Ct-299 [**2140-9-21**] 05:51AM BLOOD Glucose-115* UreaN-15 Creat-1.5* Na-139 K-4.0 Cl-106 HCO3-26 AnGap-11 [**2140-9-20**] 03:31AM BLOOD ALT-9 AST-12 AlkPhos-53 TotBili-0.1 [**2140-9-21**] 05:51AM BLOOD Calcium-8.2* Phos-4.8* Mg-1.7 [**2140-9-20**] 11:00PM BLOOD CK-MB-2 cTropnT-<0.01  PERTINENT LABS [**2140-9-17**] 07:10AM BLOOD ALT-11 AST-17 LD(LDH)-298* AlkPhos-68 TotBili-0.1 [**2140-9-18**] 02:55AM BLOOD ALT-8 AST-13 AlkPhos-56 TotBili-0.1 [**2140-9-20**] 03:31AM BLOOD ALT-9 AST-12 AlkPhos-53 TotBili-0.1 [**2140-9-15**] 03:00PM BLOOD Lipase-12 [**2140-9-20**] 11:00PM BLOOD CK-MB-2 cTropnT-<0.01  Microbiology: no pertinent  PERTINENT STUDIES CXR [**9-15**] FINDINGS:  PA and lateral views of the chest are compared to previous exam from [**2140-6-25**].
There are vague rounded opacities projecting over the right mid-to-lower lung seen over the anterior and lateral ribs, suggesting healing fractures.
Started on Insulin drip with q1hr glucose checks, and insulin gtt .
Remained on insulin drip due to intolerance of PO diet.
Able to tolerate PO overnight [**9-19**], DC'd insulin gtt.
Currently nausea/vomiting is well-controlled in-hospital with clonidine patch and PRN Ativan, Zofran, and Dimenhydrinate.
It is unclear the long term benefit of clonidine in her given for the most time in-between her flares, she is asymtpomatic.
# Hypertensive Urgency - Patient had labile pressures while in the MICU with sBPs>200, which was controlled in MICU with labetolol drop and IV labetolol.
Prior the  transfer to the floor, patient was transitioned to amlodopine 5mg QD and clonidine patch with adequate control of BP.
Her blood pressure medication has been weaned off by her PCP to prevent hypotension.
After discussion with her PCP, [**Name10 (NameIs) **] decided to discontinue her blood pressure medication started as inpatient and continue outpatient followup.
GI consult saw in-house, and recommended conservative management with pantoprazole.
Patient was placed on PPI and crossmatched with PIV in place.
Following IV hydration patient was noted to have a down trend in her BUN and [**Last Name (un) **].
CHRONIC ISSUES # Depression / anxiety - continued on home Sertraline and Ativan  # Neuropathy - continued on home gabapentin  TRANSIONAL ISSUES # Code status: Full code # Pending studies: None # Medication changes:  - Dimenhydrinate 50 mg PO PRN nausea/vomiting # FOLLOWUP PLAN  - PCP followup on [**9-27**]  - [**Last Name (un) **] diabetes followup on [**9-23**]  Attending addendum:  After speaking with PCP, [**Name10 (NameIs) **] was decided to stop all blood pressure medications upon discharge as patient was profoundly orthostatic.
Medications on Admission: Preadmission medications listed are correct and complete.
Gabapentin 800 mg PO HS 2.
Sertraline 100 mg PO DAILY 3.
Glargine 10 Units Breakfast Insulin SC Sliding Scale using HUM Insulin 5.
Ferrous Sulfate 325 mg PO DAILY 6.
Vitamin D Dose is Unknown  PO DAILY 7.
Calcium Carbonate Dose is Unknown  PO Frequency is Unknown 8.
Simvastatin 20 mg PO DAILY 9.
Omeprazole 40 mg PO DAILY 10.
Metoclopramide 10 mg PO Frequency is Unknown   Discharge Medications: 1.
Gabapentin 800 mg PO HS 2.
Calcium Carbonate 500 mg PO QID:PRN upset stomach 3.
Sertraline 100 mg PO DAILY 4.
Glargine 10 Units Breakfast Insulin SC Sliding Scale using HUM Insulin 5.
Ferrous Sulfate 325 mg PO DAILY 6.
Metoclopramide 10 mg PO HS:PRN heartburn 7.
Omeprazole 40 mg PO DAILY 8.
Atorvastatin 20 mg PO DAILY 9.
Torsemide 10 mg PO DAILY 10.
Vitamin D [**2128**] UNIT PO DAILY   Discharge Disposition: Home  Discharge Diagnosis: Primary Diagnosis: Diabetic ketoacidosis with gastroparesis Secondary Diagnoses: Hypertensive urgency, anemia due to [**Doctor First Name **]-[**Doctor Last Name **] tear, chronic kidney disease.
Followup Instructions: Department: Endocrinology- [**Last Name (un) **] Diabetes Center Name: Dr. [**First Name (STitle) 16433**] [**Name (STitle) **] for Dr. [**First Name4 (NamePattern1) 553**] [**Last Name (NamePattern1) 20556**] When: [**Last Name (NamePattern1) 2974**] [**2140-9-23**] at 9:30 AM Location: [**Last Name (un) **] DIABETES CENTER Address: ONE [**Last Name (un) **] PLACE, [**Apartment Address(1) 20557**], [**Location (un) **],[**Numeric Identifier 718**] Phone: [**Telephone/Fax (1) 2490**]  Department: [**Hospital3 249**] When: TUESDAY [**2140-9-27**] at 3:10 PM With: [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **], MD [**Telephone/Fax (1) 2010**] Building: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) **] Campus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage  Department: [**Hospital3 249**] When: MONDAY [**2140-10-24**] at 8:20 AM With: [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **], MD [**Telephone/Fax (1) 2010**] Building: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) **] Campus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage
